Neuroblastoma

Jun 03, 2020

Clarity Pharmaceuticals Announces that the US FDA Grants Rare Pediatric Disease Designation to 67Cu-SARTATE(TM) for the Treatment of Neuroblastoma

Apr 21, 2020

Clarity Pharmaceuticals Announces US FDA Grants 67Cu-SARTATE(TM) Orphan Drug Designation for Neuroblastoma

Oct 17, 2019

Researchers Identify Targeted Therapy That Can Help Children With Deadly Nerve Cancer

May 29, 2019

EUSA Pharma Announces New QARZIBA(R) (Dinutuximab beta) Data to Be Presented at 2019 ASCO Annual Meeting

Mar 27, 2019

The neuroblastoma drugs market will register a CAGR of over 4% by 2023

Jan 30, 2019

International Research Team Led by Australian Scientists Discover a Potential Way to Treat and Prevent Cancer in Children with Neuroblastoma

Dec 20, 2018

Exciting Research Shows Vaccines Effective in Treating Childhood Cancer

Sep 06, 2018

Band of Parents Launches Digital Series Celebrating Kid Warriors in Honor of Pediatric Cancer Awareness Month

Mar 01, 2018

EnGeneIC Announces Publication of Preclinical Data Highlighting Potential Efficacy of EGFR-Targeted EDV(TM) Nanocells to Treat Pediatric Neuroblastoma

Dec 18, 2017

Europe Neuroblastoma Market and Competitive Landscape 2012-2017 & Forecasts to 2021 & 2025